Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
EBITDA Growth
136.30%
Quarterly · Period ending:
LCTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported136.30%period ending
Latest reported136.30%period ending
LCTX Quarterly EBITDA YoY % (-100.00% → 136.30%)
Year-over-year change
High-resolution chart · PNG
LCTX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 136.2969% | |
| -15.6321% | |
| -35.5921% | |
| -934.0559% | |
| 15.3081% | |
| 37.6625% | |
| 31.725% | |
| 59.0375% | |
| -11.8816% | |
| -5.7488% | |
| 26.6602% | |
| -29.7287% | |
| 23.7309% | |
| 12.7115% | |
| 77.7518% | |
| 37.7588% | |
| -38.489% | |
| -2.2324% | |
| -401.5867% | |
| -37.7788% | |
| 18.6582% | |
| -0.5351% | |
| 9.6448% | |
| 18.0786% | |
| 41.8272% | |
| 43.966% | |
| 35.1916% | |
| 19.7969% | |
| -21.5743% | |
| -14.0916% | |
| -8.8245% | |
| -10.0207% | |
| 13.0941% | |
| -0.766% | |
| 16.534% | |
| -0.2078% | |
| 27.2776% | |
| 52.5596% | |
| 48.0831% | |
| 44.1968% | |
| -9.8299% | |
| -84.6122% | |
| -39.4299% | |
| -47.8808% | |
| -4.4195% | |
| -25.3561% | |
| -40.8114% | |
| -11.7751% | |
| -55.821% | |
| -24.776% | |
| -63.0747% | |
| -80.4275% | |
| -35.9071% | |
| -44.0903% | |
| -25.9414% | |
| -48.1076% | |
| -24.5506% | |
| -44.2236% | |
| -55.1189% | |
| -57.4436% | |
| -100.0035% | |
| -178.8387% | |
| -284.1651% | |
| 23.6964% | |
| -97.0454% | |
| -45.6868% | |
| 281.691% | |
| -220.1667% | |
| -26.5163% | |
| -153.2062% | |
| -272.8173% | |
| -514.8965% | |
| -203.5261% | |
| 29.7774% | |
| 87.9074% | |
| 30.2363% | |
| 54.7225% | |
| -10.5094% | |
| -361.8032% | |
| 47.1181% | |
| -48.5242% | |
| 36.3911% | |
| 22.3656% | |
| 1.1579% | |
| 2.677% | |
| -239.2891% | |
| -368.1499% | |
| -187.0472% | |
| -46.0943% | |
| 266.7873% | |
| 72.5969% | |
| -1,607.4318% | |
| 48.264% | |
| 26.7159% | |
| -141.8077% | |
| 101.0282% | |
| 47.8066% | |
| 54.7904% | |
| 81.255% | |
| 27.6577% |